As a result of screening 46 antibodies directed against defined regions of rhodopsin, we identified a monoclonal antibody, which also recognizes opiate receptors from NG108-15 neuroblastoma x glioma hybrid cells. A peptide corresponding to the epitope of the antibody inhibits precipitation of opiate receptors by the antibody. A peptide from the homologous region of the porcine brain muscarinic receptor not only blocks the antibody, but also activates a number of G-proteins both in membranes and in solutions of the purified proteins. Homologous peptide fragments of other receptors also activate the appropriate G-proteins. These experiments suggest that we have identified an important region of the signal transmitting domain of G-protein coupled receptors. In related experiments, we have shown that the alkylating GTP analogue fluorosulfonylbenzoylguanosine (FSBG) can be used as a reagent to inactivate G-proteins in natural membranes without affecting receptor numbers of effector enzymes directly. Thus, FSBG treatment of NG108-15 membranes prevents bradykinin stimulation of phospholipase C activity without changing receptor numbers of the intrinsic or calcium activated enzyme activity. Bradykinin sensitivity can be restored to the treated membranes by addition of purified G-proteins.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Intramural Research (Z01)
Project #
1Z01MH000934-17
Application #
3921900
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
17
Fiscal Year
1988
Total Cost
Indirect Cost
Name
U.S. National Institute of Mental Health
Department
Type
DUNS #
City
State
Country
United States
Zip Code